Neuroxon, solution for injection and Neuroxon peroral were registered in Kazakhstan
Two dosage forms of Neuroxon, solution for injection and peroral solution, were registered in Kazakhstan in January 2014. Neuroxon is a generic drug that has proven efficacy, safety and therapeutic equivalence to the original Citicoline.
Vascular pathology in the brain is an extremely acute problem all over the world. Presently, neuroprotection is one of the most important methods of treating ischemic stroke and craniocerebral injuries. It refers to preservation and restoration of neuronal function of the brain. One of the drugs used in neuroprotection is Citicoline. In generic Neuroxon patients receive a quality and efficacious drug that helps undergo the full treatment and rehabilitation course.
In Ukraine, Neuroxon, solution for injection and Neuroxon, peroral solution were registered in 2012 and have since been actively used in medical practice. In 2013 Arterium also began marketing Neuroxon tablets in Ukraine.
Information about the drug provided in brief form. For complete information, please refer to the patient information leaflet: Neuroxon, solution for injection and Neuroxon peroral.
This website is a specialized publication intended for healthcare professionals.